Endophthalmitis Postoperative

2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
2
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

S
SantenCA - Emeryville
2 programs
2
Levofloxacin OphthalmicPhase 1/21 trial
Levofloxacin Ophthalmic ProductPhase 1/21 trial
Active Trials
NCT04212078UnknownEst. Oct 2022
NCT04212429UnknownEst. May 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SantenLevofloxacin Ophthalmic Product
SantenLevofloxacin Ophthalmic

Clinical Trials (2)

NCT04212429SantenLevofloxacin Ophthalmic Product

The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%

Start: Sep 2019Est. completion: May 2022
Phase 1/2Unknown
NCT04212078SantenLevofloxacin Ophthalmic

Intracameral Levofloxacin (0.5%) vs Intracameral Cefuroxime

Start: Jul 2019Est. completion: Oct 2022
Phase 1/2Unknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space